Boai NKY (China) Today
| 300109 Stock | 15.90 0.08 0.51% |
PerformanceInsignificant
| Odds Of DistressLow
|
Boai NKY is trading at 15.90 as of the 1st of March 2025, a 0.51 percent increase since the beginning of the trading day. The stock's open price was 15.82. Boai NKY has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. The performance scores are derived for the period starting the 12th of March 2023 and ending today, the 1st of March 2025. Click here to learn more.
Moving together with Boai Stock
| 0.75 | 600309 | Wanhua Chemical Group | PairCorr |
| 0.73 | 002493 | Rongsheng Petrochemical | PairCorr |
| 0.86 | 600010 | Inner Mongolia BaoTou | PairCorr |
Moving against Boai Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Boai Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Boai NKY's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Boai NKY or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman GM | Junzheng Zhang |
| Business Concentration | Commodity Chemicals, Specialty Chemicals, Basic Materials, Materials, Chemicals, Drug Manufacturers - General, Healthcare (View all Sectors) |
Boai NKY Pharmaceuticals (300109) is traded on Shenzhen Stock Exchange in China and employs 1,165 people. Boai NKY is listed under Commodity Chemicals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.67 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Boai NKY's market, we take the total number of its shares issued and multiply it by Boai NKY's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Boai NKY Pharmaceuticals operates under Chemicals sector and is part of Materials industry. The entity has 484.7 M outstanding shares.
Boai NKY generates positive cash flow from operations, but has no cash available
Check Boai NKY Probability Of Bankruptcy
Ownership AllocationBoai NKY holds a total of 484.7 Million outstanding shares. Boai NKY Pharmaceuticals retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Boai Ownership Details
Boai NKY Pharmaceuticals Risk Profiles
Although Boai NKY's alpha and beta are two of the key measurements used to evaluate Boai NKY's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.59 | |||
| Semi Deviation | 2.78 | |||
| Standard Deviation | 4.0 | |||
| Variance | 16.02 |
Boai Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Boai NKY without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Boai NKY Corporate Management
Elected by the shareholders, the Boai NKY's board of directors comprises two types of representatives: Boai NKY inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Boai. The board's role is to monitor Boai NKY's management team and ensure that shareholders' interests are well served. Boai NKY's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Boai NKY's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ai Liu | Chief Officer | Profile | |
| Shegang Li | Deputy Manager | Profile | |
| Haizhan Mao | Deputy Manager | Profile | |
| Dedong Zhang | Deputy Manager | Profile | |
| Shigang Wang | Deputy Manager | Profile | |
| Xiaowen Zou | Deputy Manager | Profile |
Other Information on Investing in Boai Stock
Boai NKY financial ratios help investors to determine whether Boai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boai with respect to the benefits of owning Boai NKY security.